About
Cancer Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalJapan
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
611
By Phase
PHASE1/PHASE2: 2PHASE3: 1PHASE1: 2
By Status
RECRUITING: 3COMPLETED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06382168Lead Sponsor
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
39 participants
Started: Jun 12, 2024 · Completed: Jun 30, 2026
NCT03926624Lead Sponsor
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
PHASE3Recruiting
450 participants
Started: Nov 22, 2019 · Completed: Jun 30, 2026
NCT03943004Lead Sponsor
Trial of DFP-14927 in Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Sep 30, 2019 · Completed: Jun 1, 2026
NCT02171221Lead Sponsor
Phase I Study of Oral DFP-11207 in Solid Tumors
PHASE1Completed
23 participants
Started: Jun 30, 2014 · Completed: Sep 13, 2018
NCT01702155Lead Sponsor
Phase I/II Study of DFP-10917 in Patients With Acute Leukemia
PHASE1/PHASE2Completed
69 participants
Started: Oct 10, 2012 · Completed: Oct 11, 2017
Locations (1)
Headquarters
Tokyo, Japan
Map
Loading map...